Differentiating Parkinson’s disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test
✍ Scribed by Akio Kikuchi; Toru Baba; Takafumi Hasegawa; Naoto Sugeno; Masatoshi Konno; Atsushi Takeda
- Book ID
- 116821044
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 175 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1353-8020
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Parkinson's disease (PD) with autonomic dysfunction is difficult to differentiate from Parkinsonism‐predominant multiple system atrophy (MSA‐p). This study aimed to analyze the validity of MIBG scintigraphy for PD with autonomic dysfunction and MSA‐p. Thirty‐nine patients (PD: 27 patien
## Abstract Both dopamine D2 receptor (D2R) binding single‐photon emission computed tomography (SPECT) with [^123^I]iodobenzamide (IBZM) and diffusion‐weighted imaging (DWI) have been shown to contribute to the differential diagnosis of patients with the Parkinson variant of multiple system atrophy